Esperoct Kit
Product Images NDC 0169-8500

39 FDA label images from Novo Nordisk · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Esperoct (NDC 0169-8500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Esperoct (Overview)

Esperoct (Overview)
Illustration showing the components of the ESPEROCT kit by Novo Nordisk, including a vial with ESPEROCT powder, vial adapter with protective cap and spike, a pre-filled syringe with diluent featuring syringe cap, tip, scale, and rubber plunger, and a plunger rod with thread and wide top end.*
FDA Label Image

Fig. A (Image 02)

Fig. A (Image 02)
An instructional illustration showing two hands holding components of a medication kit. The left hand holds a syringe plunger, and the right hand holds a small vial or container, indicating preparation steps for use.*
FDA Label Image

Fig. B (Image 03)

Fig. B (Image 03)
An instructional illustration showing a hand gripping a vial and indicating an upward pulling motion to remove the vial cap, labeled step B in a series for medication preparation or administration.*
FDA Label Image

Fig. C (Image 04)

Fig. C (Image 04)
An instructional illustration showing two hands, one holding a small container and the other peeling off or lifting a seal or cover from it, indicated by an upward arrow. The image is labeled with a letter 'C' in the top left corner, suggesting part of a step-by-step process.*
FDA Label Image

Fig. D (Image 05)

Fig. D (Image 05)
An instructional illustration showing a hand pressing down on the cap of a vial, indicating how to remove or secure the vial cap. The image is labeled with a letter 'D' in the top left corner, suggesting a step in a sequence.*
FDA Label Image

Fig. E (Image 06)

Fig. E (Image 06)
An instructional illustration showing a hand lifting a cap or stopper upwards off a vial, with a zoomed inset highlighting the vial and cap. The image likely demonstrates how to open or prepare the vial in the ESPEROCT kit.*
FDA Label Image

Fig. F (Image 07)

Fig. F (Image 07)
An instructional illustration showing hands holding a syringe and a plunger. The image depicts a twisting or turning motion indicated by an arrow, suggesting assembly or preparation of the syringe, likely part of the dosing or administration process for ESPEROCT kit.*
FDA Label Image

Fig. G (Image 08)

Fig. G (Image 08)
Instructional illustration showing hands connecting or assembling two components. The left hand holds a device part with a small rectangular end, and the right hand holds a corresponding cap or cover, with an arrow indicating to attach the two parts together.*
FDA Label Image

Fig. H (Image 09)

Fig. H (Image 09)
Instructional illustration showing a pair of hands holding two parts of a medical kit, with an arrow indicating the action to twist or connect the components. The background is light blue with a small 'H' in the upper left corner, likely part of a step-by-step usage guide for the ESPEROCT kit.*
FDA Label Image

Fig. I (Image 10)

Fig. I (Image 10)
Instructional illustration showing a syringe being held by a hand with the thumb pressing the plunger. The syringe tip is attached to a vial or connector, indicated by an arrow pointing toward the syringe tip. The background is light blue with a rounded square inset label marked 'I'.*
FDA Label Image

Fig. J (Image 11)

Fig. J (Image 11)
Instructional illustration showing a hand holding a syringe, preparing to twist or rotate a component at the syringe tip, indicated by a circular arrow around the connection point. The style suggests guidance on assembling or using the syringe within the ESPEROCT kit.*
FDA Label Image

Fig. K (Image 12)

Fig. K (Image 12)
An instructional illustration showing a hand holding a syringe connected to a vial. The syringe plunger is being pushed downwards, indicated by a downward arrow. This image likely demonstrates part of the preparation or administration process for the ESPEROCT kit by Novo Nordisk.*
FDA Label Image

Esperoct (Overview)

Esperoct (Overview)
An illustration diagram titled 'Overview' showing components of the ESPEROCT kit. It includes labeled images of the vial with ESPEROCT powder featuring a plastic cap and rubber stopper, a vial adapter with protective cap and spike under protective paper, a pre-filled syringe with diluent showing the syringe tip, cap, scale, and rubber plunger, and a plunger rod with thread and wide top end.*
FDA Label Image

Symbol (Image 14)

Symbol (Image 14)
FDA Label Image

Fig. A (Image 18)

Fig. A (Image 18)
Illustration showing a pair of hands holding two separate components of a kit, with the left hand gripping a syringe and the right hand holding a small vial or bottle. The image is likely part of an instructional diagram related to ESPEROCT, antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. B (Image 19)

Fig. B (Image 19)
An instructional illustration showing a hand holding a vial with the thumb pushing upward on the vial cap, indicating how to remove the cap from the vial. The image has a letter 'B' in the top left corner, suggesting it is part of a step-by-step guide for ESPEROCT kit use.*
FDA Label Image

Fig. C (Image 20)

Fig. C (Image 20)
An instructional illustration showing a pair of hands peeling or lifting the foil lid from a small plastic cup or container, with an upward arrow indicating the direction to remove the lid.*
FDA Label Image

Fig. D (Image 21)

Fig. D (Image 21)
An instructional diagram showing a hand pressing down on a cap or lid above a vial, indicating the action of placing or removing the cap from the vial. The image suggests a step in the preparation or handling of medication but contains no text or detailed instructions.*
FDA Label Image

Fig. E (Image 22)

Fig. E (Image 22)
Instructional illustration showing a hand removing a cap by pulling it upward from a vial or container, likely depicting part of the preparation process for ESPEROCT antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. F (Image 23)

Fig. F (Image 23)
An instructional illustration showing two hands holding a syringe or similar cylindrical device horizontally, with an arrow indicating a twisting or rotating motion. This likely depicts a step in the preparation or assembly process of the ESPEROCT kit.*
FDA Label Image

Fig. G (Image 24)

Fig. G (Image 24)
Instructional illustration showing two hands opening a small vial or container by twisting off the cap, indicated by an arrow pointing from the closed vial to the open vial. The background is light blue with a blue letter 'G' in the upper left corner.*
FDA Label Image

Fig. H (Image 25)

Fig. H (Image 25)
An instructional illustration showing hands connecting two parts of a medical device or kit, with an arrow indicating the direction of attachment or twisting. The image is related to ESPEROCT, an antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. I (Image 26)

Fig. I (Image 26)
Illustration showing a hand holding a syringe with an arrow indicating the plunger being pushed. This image appears to be an instructional step related to the preparation or administration of ESPEROCT, an antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. J (Image 27)

Fig. J (Image 27)
An instructional diagram showing a hand holding a syringe-like device that is being rotated or twisted, indicated by a circular arrow around the device. The image likely depicts a step in the preparation or assembly of the ESPEROCT kit components.*
FDA Label Image

Symbol (Image 28)

Symbol (Image 28)
FDA Label Image

Fig. K (Image 29)

Fig. K (Image 29)
An instructional illustration showing a hand holding a syringe, with an arrow pointing downward, indicating the action of pushing the plunger. The background is shaded in light blue and contains a small 'K' icon at the top left.*
FDA Label Image

Fig. L (Image 30)

Fig. L (Image 30)
Instructional illustration showing how to connect parts of a syringe or injection device, with a hand holding and twisting a cap or connector onto the syringe barrel, indicated by a curved arrow.*
FDA Label Image

Fig. M (Image 31)

Fig. M (Image 31)
An instructional illustration showing the use of a vial and syringe with a storage container. The image depicts a syringe drawing liquid from a vial, followed by an action of inserting or depositing the syringe into a round container with a multi-slit opening on its lid.*
FDA Label Image

500 Iu Carton (Image 32)

500 Iu Carton (Image 32)
Packaging label for ESPEROCT 500 IU Kit containing antihemophilic factor (recombinant), glycopegylated-exei. The label shows the product name, strength of 500 IU, kit dosage form, and includes instructions indicating intravenous use after reconstitution. It also notes the inclusion of a vial adapter and pre-filled diluent syringe. The labeler is Novo Nordisk.*
FDA Label Image

1000 Iu Carton (Image 33)

1000 Iu Carton (Image 33)
Box label for ESPEROCT 1000 IU kit, containing antihemophilic factor (recombinant), glycopegylated-exei. The label indicates it is a plasma derivative for injection after reconstitution. The package includes a vial adapter and pre-filled diluent syringe. Manufactured by Novo Nordisk.*
FDA Label Image

1500 Iu Carton (Image 34)

1500 Iu Carton (Image 34)
Packaging label for ESPEROCT 1500 IU Kit, a plasma derivative containing antihemophilic factor (recombinant), glycopegylated-exei. The label features dosage strength 1500 IU, usage instructions for intravenous use after reconstitution, and a graphic of a syringe and vial. The product is labeled for single-dose use and includes a vial adapter and pre-filled diluent syringe. Labeler is Novo Nordisk.*
FDA Label Image

2000 Iu Carton (Image 35)

2000 Iu Carton (Image 35)
ESPEROCT 2000 IU kit packaging label for antihemophilic factor (recombinant), glycopegylated-exei by Novo Nordisk. The label shows product name, strength (2000 IU), dosage form as a kit, and includes instructions for single-dose intravenous use after reconstitution. The label also depicts a vial adapter and pre-filled diluent syringe illustration and includes storage and handling information.*
FDA Label Image

3000 Iu Carton (Image 36)

3000 Iu Carton (Image 36)
Packaging label for ESPEROCT 3000 IU KIT, containing antihemophilic factor (recombinant), glycopegylated-exei. The label displays the product name, active ingredient, strength (3000 IU), and dosage form as a kit. It includes usage instructions for intravenous use, notes on no preservatives, and mentions components like a vial adapter and pre-filled diluent syringe. The labeler Novo Nordisk is also shown.*
FDA Label Image

Syringe Label (Image 37)

Syringe Label (Image 37)
A vial label for Sodium chloride 4 mL used for reconstitution of ESPEROCT, labeled as single-dose and prescription only. The label includes storage instructions to refrigerate between 36°F to 46°F (2°C to 8°C) and to not freeze. Manufacturer information shows Novo Nordisk Inc. with a contact number. Barcode and expiration/lot number sections are present.*
FDA Label Image

500 Iu Vial (Image 38)

500 Iu Vial (Image 38)
Label for ESPEROCT 500 IU Range kit containing antihemophilic factor (recombinant), glycopegylated-exei. The label instructs to store the product refrigerated at 36°F to 46°F (2°C to 8°C), not to freeze it, and use only with 4 mL sodium chloride for reconstitution. The product is Rx only and labeled by Novo Nordisk Inc.*
FDA Label Image

1000 Iu Vial (Image 39)

1000 Iu Vial (Image 39)
Packaging label for ESPEROCT kit containing antihemophilic factor (recombinant), glycopegylated-exei. The label includes storage instructions to keep refrigerated at 36°F-46°F (2°C-8°C) and not to freeze. It specifies reconstitution with 4 mL sodium chloride solution and states the 1000 IU range dosage. Labeler is Novo Nordisk Inc.*
FDA Label Image

1500 Iu Vial (Image 40)

1500 Iu Vial (Image 40)
ESPEROCT kit packaging label showing antihemophilic factor (recombinant), glycopegylated-exei. The label includes NDC 0169-8151-11, instructions for reconstitution with 4 mL sodium chloride solution, storage between 36°F-46°F (2°C-8°C), and warnings not to freeze. Manufactured by Novo Nordisk Inc., with a contact number 1-800-727-6500. Contains vial labels with dosage strength of 1500 IU range.*
FDA Label Image

2000 Iu Vial (Image 41)

2000 Iu Vial (Image 41)
ESPEROT antihemophilic factor (recombinant), glycopegylated-exei kit label with NDC 0169-8201-11. The label includes storage instructions to keep refrigerated at 2°C to 8°C and not to freeze. It specifies reconstitution with 4 mL sodium chloride solution, covers a 2000 IU range, and notes the product is Rx only. Novo Nordisk is the labeler.*
FDA Label Image

3000 Iu Vial (Image 42)

3000 Iu Vial (Image 42)
The packaging label for ESPEROCT includes its proprietary name and identifies it as antihemophilic factor (recombinant), glycopegylated-exei. The label indicates a 3000 IU range, specifying reconstitution with 4 mL sodium chloride solution only. Storage instructions advise refrigeration at 36°F to 46°F (2°C to 8°C) and to avoid freezing. It also states Rx Only and provides the labeler as Novo Nordisk Inc with a customer service number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.